Cargando…
10399 DNA-PK(cs) Regulates Stability of Egr1 During T Cell Activation
ABSTRACT IMPACT: This work provides supporting evidence for the development of a novel immunosuppression therapy for transplant patients. OBJECTIVES/GOALS: Our laboratory reported that inhibition of the kinase DNA-PK(cs) in mice delays allogeneic graft rejection in part by mitigating the induction o...
Autores principales: | Waldrip, Zachary, Harrison, David, Burdine, Marie, Burdine, Lyle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827746/ http://dx.doi.org/10.1017/cts.2021.420 |
Ejemplares similares
-
DNA-PKcs kinase activity stabilizes the transcription factor Egr1 in activated immune cells
por: Waldrip, Zachary J., et al.
Publicado: (2021) -
Proteomic Identification of DNA-PK Involvement within the RET Signaling Pathway
por: Burdine, Lyle J., et al.
Publicado: (2015) -
DNA-PKcs controls calcineurin mediated IL-2 production in T lymphocytes
por: Kim Wiese, Ara, et al.
Publicado: (2017) -
Autophosphorylation of DNA-PK(CS) regulates its dynamics at DNA double-strand breaks
por: Uematsu, Naoya, et al.
Publicado: (2007) -
Ipilimumab-induced colonic perforation
por: Burdine, Lyle, et al.
Publicado: (2014)